| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d0446a5bd77c7da68216fc2e3f05d48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 |
| filingDate |
2014-08-29^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c79efdd2befd4e84c87c24b608df6c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a911619eb3b215c73f80c835b4f794f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3118bdd3b1a8fbaf3462c2617692be91 |
| publicationDate |
2016-07-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016206592-A1 |
| titleOfInvention |
Method for treating amyotrophic lateral sclerosis by inhibition of cxcr4/cxcl12 signaling |
| abstract |
The present invention provides use of an inhibitor of G protein-coupled receptor CXCR4 for treating amyotrophic lateral sclerosis (ALS), for inhibiting glutamate release in astrocytes, or for increasing remyelinization in motor neurons. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3996703-A4 |
| priorityDate |
2013-08-30^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |